← Back to headlines
Bank of America Identifies Major Upside Potential in Biosimilar Developer
Wall Street analysts point to favorable regulatory changes and upcoming product launches as catalysts for significant growth in a targeted biosimilar pharmaceutical company.
28 Aug, 15:33 — 28 Aug, 15:33
Sources
Showing 1 of 1 sources
Related Stories
HDFC Bank CEO Sashidhar Jagdishan to Step Down in October
1h ago
FSSAI Bans Everest and Laljee Godhoo From Selling Substandard Hing Powder
2h ago
UAE Central Bank Launches Probe Into Banque Misr Over US Money Laundering Warnings
3h ago
S&P, Nasdaq end lower after Fed Chair Warsh reaffirms inflation fight - Reuters
3h ago